Virchow Laboratories

Planning in...

 

Over the last couple of years, Virchow Laboratories have developed very positively, i.e. in conventional histology, immune pathology and molecular pathology. All three areas are essential building blocks of optimal precision medicine, which today play a major role in oncology, infectiology, chronic inflammatory diseases and cardiology.

Currently, intensive negotiations are being conducted with other universities and large state pathology institutes in order to introduce internationally controlled molecular diagnostics and in a second step comprehensive cancer centers. The blueprint for these structures are the analogue units at the Charité Berlin. These activities are is further building blocks in the planned network of morphology, immunology, molecular diagnostics and clinically relevant analytical systems. According to current planning, the corresponding contracts and legal framework conditions will be in place by the end of 2018.